Literature DB >> 10408308

Adenosquamous carcinoma of the prostate.

O I Turhan1, N E Aydin, O Sariyüce.   

Abstract

We present an unusual variant of prostatic adenocarcinoma with obvious squamous differentiation. The squamous component is represented by cells that contain vesicular or hyperchromatic nuclei and large acidophilic cytoplasm. We could demonstrate immunohistochemically the presence of prostate specific antigen (PSA) and glial fibrillary acidic protein (GFAP) in these tumour cells. Either in adenocarcinomatous or malignant squamous components, the prostatic epithelial cells showed the two markers, namely PSA, GFAP, which may reflect the multidirectional differentiation of these cells from a pluripotent origin.

Entities:  

Mesh:

Year:  1999        PMID: 10408308     DOI: 10.1023/a:1007180024991

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  4 in total

1.  Adenosquamous carcinoma of the prostate.

Authors:  T N Moyana
Journal:  Am J Surg Pathol       Date:  1987-05       Impact factor: 6.394

2.  Adenosquamous carcinoma of the prostate.

Authors:  P Gattuso; H J Carson; A Candel; M J Castelli
Journal:  Hum Pathol       Date:  1995-01       Impact factor: 3.466

3.  Adenosquamous carcinoma of the prostate.

Authors:  R Saito; B K Davis; E P Ollapally
Journal:  Hum Pathol       Date:  1984-01       Impact factor: 3.466

Review 4.  Grading prostate cancer.

Authors:  D G Bostwick
Journal:  Am J Clin Pathol       Date:  1994-10       Impact factor: 2.493

  4 in total
  1 in total

1.  Genomic analysis of circulating tumor cells in adenosquamous carcinoma of the prostate: a case report.

Authors:  Junji Kitamura; Satoru Taguchi; Takatsugu Okegawa; Kazuki Honda; Toshihiko Kii; Yoshihiro Tomida; Ryuki Matsumoto; Naoki Ninomiya; Kazuki Masuda; Yu Nakamura; Tsuyoshi Yamaguchi; Manami Kinjo; Mitsuhiro Tambo; Aya Isomura; Akimasa Hayashi; Hiroshi Kamma; Eiji Higashihara; Junji Shibahara; Hiroshi Fukuhara
Journal:  BMC Med Genomics       Date:  2021-09-03       Impact factor: 3.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.